CTXR Citius Pharmaceuticals, Inc.

Fundamentals / CIK 0001506251 / USD

Citius Pharmaceuticals, Inc. reported $142.3M in total assets and a net loss of $46.27M through September 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CTXR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$4.33M$2.17M$0-$37.58MFY 2016 Net Income: -$8.30M2016FY 2017 Revenue: $50KFY 2017 Net Income: -$10.38M2017FY 2018 Revenue: $75KFY 2018 Net Income: -$12.54M2018FY 2019 Revenue: $90KFY 2019 Net Income: -$15.56M2019FY 2020 Revenue: $90KFY 2020 Net Income: -$17.55M2020FY 2021 Revenue: $90KFY 2021 Net Income: -$23.05M2021FY 2022 Revenue: $90KFY 2022 Net Income: -$33.64M2022FY 2023 Net Income: -$32.54M2023FY 2024 Net Income: -$40.19M2024FY 2025 Net Income: -$37.43M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Revenue -- -- -- $90K $90K $90K $90K $75K $50K --
Cost of Revenue -- -- -- -- -- -- -- $75K $50K $45K
Gross Profit -- -- -- -- -- -- -- $0 $0 --
Research & Development $9.16M $11.91M $14.82M $17.66M $12.24M $8.81M $8.60M $6.56M $2.94M $2.93M
Total Operating Expenses $38.53M $42.00M $36.73M $33.32M $23.53M $17.71M $15.60M $13.79M $9.99M $7.45M
Operating Income -$38.53M -$42.00M -$36.73M -$33.32M -$23.53M -$17.71M -$15.60M -$13.79M -$9.99M -$7.45M
EBITDA -- -$41.99M -$36.73M -$33.31M -$23.53M -$17.71M -$15.60M -$13.79M -$9.98M -$7.45M
Interest Income $110K $758K $1.18M $251K $262K $68K $53K -- -- $806
Interest Expense $268K -- -- -- $11K $16K $16K $16K $851K $9.0K
Income Before Tax -$38.68M -$38.85M -$31.97M -$33.06M -$23.05M -$17.55M -$15.56M $12.54M $10.38M -$8.30M
Income Tax Expense $1.06M $576K $576K $576K $1.2K $741 -- -- -- --
Net Income -$37.43M -$40.19M -$32.54M -$33.64M -$23.05M -$17.55M -$15.56M -$12.54M -$10.38M -$8.30M
Basic EPS -$3.38 -$5.97 -$5.57 -$0.23 -$0.23 -$0.45 -$0.77 -$1.17 -$1.89 -$2.29
Diluted EPS -$3.38 -$5.97 -$5.57 -$0.23 -$0.23 -$0.45 -$0.77 -$1.17 -$1.89 -$2.29
Basic Shares Outstanding 11.1M 6.7M 6.1M 146.1M 108.6M 39.2M 20.2M 10.7M 5.5M 3.6M
Diluted Shares Outstanding 11.1M 6.7M 6.1M 146.1M 108.6M 39.2M 20.2M 10.7M 5.5M 3.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue $1.49M $1.67M $3.94M -- -- -- -- --
Cost of Revenue $492K $329K $789K -- -- -- -- --
Gross Profit $1.00M $1.34M $3.15M -- -- -- -- --
Research & Development $1.05M $1.63M $1.60M $1.64M $1.62M $3.77M $2.13M $2.91M
Total Operating Expenses $12.73M $33.53M $12.17M $8.44M $8.79M $11.26M $10.04M $11.05M
Operating Income -$11.73M -$32.19M -$9.02M -$8.44M -$8.79M -$11.26M -$10.04M -$11.05M
EBITDA -- -- -- -- -- -- -- -$11.05M
Interest Income $117K $54K $45K $53K $21K $13K $23K $117K
Interest Expense $198K $33K $156K -- $172K -- -- --
Income Before Tax -$12.03M -$28.34M -$9.13M -$8.48M -$8.94M -$11.25M -$10.02M -$10.93M
Income Tax Expense -$107K -$231K $264K $264K $264K $264K $264K $144K
Net Income -$8.86M -$21.23M -$8.22M -$7.96M -$8.79M -$11.51M -$10.28M -$11.52M
Basic EPS -$0.34 -$0.95 -$0.38 -- -$0.80 -$1.27 -$1.30 --
Diluted EPS -$0.34 -$0.95 -$0.38 -- -$0.80 -$1.27 -$1.30 --
Basic Shares Outstanding 26.2M 22.4M 21.5M -- 11.0M 8.6M 7.5M --
Diluted Shares Outstanding 26.2M 22.4M 21.5M -- 11.0M 8.6M 7.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $4.25M $3.25M $26.48M $41.71M $70.07M $13.86M $7.89M $9.18M $3.20M $294K
Cash & Short-Term Investments $4.25M $3.25M $26.48M $41.71M $70.07M $13.86M $7.89M $9.18M $3.20M $294K
Inventory $22.29M $8.27M -- -- -- -- -- -- -- --
Other Current Assets -- -- -- -- -- -- -- -- -- $19.40M
Total Current Assets $27.93M $14.22M $34.37M $44.56M $72.81M $13.98M $7.94M $10.06M $3.42M $893K
Property, Plant & Equipment, Net -- -- $1.4K $4.1K $7.0K $1.6K $590 $1.5K $3.2K $3.7K
Goodwill $9.35M $9.35M $9.35M $9.35M $9.35M $9.35M $9.35M $1.59M $1.59M $1.59M
Other Non-Current Assets $102.2M $102.2M $68.78M -- -- -- -- -- -- --
Total Non-Current Assets $103.0M $102.4M $69.24M $69.44M $69.61M $29.79M $28.80M $20.99M $20.99M $21.06M
Total Assets $130.9M $116.7M $103.6M $114.0M $142.4M $43.77M $36.75M $31.05M $24.42M $21.95M
Accounts Payable $13.69M $4.93M $2.93M $1.17M $1.28M $1.86M $2.71M $1.57M $602K $909K
Short-Term Debt $300.0M -- -- -- -- -- -- -- -- --
Total Current Liabilities $44.91M $35.81M $5.78M $4.53M $3.98M $4.10M $4.61M $3.18M $2.47M $5.18M
Total Non-Current Liabilities $8.50M $6.74M $6.40M $6.04M $5.66M $6.01M $4.99M -$2.77M $0 $0
Total Liabilities $53.41M $42.55M $12.18M $10.57M $9.65M $10.10M $9.59M $411K $2.47M $5.18M
Total Debt (incl. Leases) $300.8M $263K $481K $678K $855K $1.01M $1.14M -- -- --
Common Stock $18K $7.2K $6.4K $146K $146K $56K $29K $16K $8.3K $4.9K
Retained Earnings -$238.8M -$201.4M -$162.2M -$129.7M -$96.05M -$70.59M -$53.05M -$40.26M -$27.72M -$17.34M
Total Stockholders' Equity $67.55M $70.08M $90.83M $102.8M $132.2M $33.67M $27.15M $30.64M $21.95M $16.77M
Total Equity $77.53M $74.10M $91.43M $103.4M $132.8M $33.67M $27.15M $30.64M $21.95M $16.77M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $17.01M $4.59M $7.72M $4.25M $6.09M $26K $1.10M $3.25M
Cash & Short-Term Investments $17.01M $4.59M $7.72M $4.25M $6.09M $26K $1.10M $3.25M
Accounts Receivable, Net $686K $1.08M $4.05M -- -- -- -- --
Inventory $22.63M $22.66M $22.64M $22.29M $17.21M $15.34M $14.38M $8.27M
Total Current Assets $43.33M $31.69M $37.95M $27.93M $24.61M $18.37M $18.33M $14.22M
Goodwill $9.35M $9.35M $9.35M $9.35M $9.35M $9.35M $9.35M $9.35M
Other Non-Current Assets $98.17M $100.1M $101.6M $102.2M $102.2M $102.2M $102.2M $102.2M
Total Non-Current Assets $98.92M $100.9M $102.4M $103.0M $103.1M $103.1M $102.4M $102.4M
Total Assets $142.3M $132.5M $140.4M $130.9M $127.7M $121.5M $120.7M $116.7M
Accounts Payable $8.04M $9.45M $11.02M $13.69M $10.09M $9.37M $7.36M $4.93M
Short-Term Debt $300.0M $300.0M $300.0M $300.0M $300.0M $300.0M $300.0M --
Total Current Liabilities $51.65M $55.02M $38.21M $44.91M $51.84M $49.88M $44.81M $35.81M
Total Non-Current Liabilities $14.70M $8.44M $8.72M $8.50M $8.27M $8.03M $6.98M $6.74M
Total Liabilities $66.35M $63.46M $46.92M $53.41M $60.12M $57.91M $51.78M $42.55M
Total Debt (incl. Leases) $300.8M $300.8M $300.8M $300.8M $300.9M $300.9M $300.2M $263K
Common Stock $27K $22K $22K $18K $14K $8.8K $7.7K $7.2K
Retained Earnings -$277.1M -$268.3M -$247.0M -$238.8M -$230.8M -$222.1M -$211.1M -$201.4M
Total Stockholders' Equity $66.61M $61.54M $79.96M $67.55M $65.06M $60.66M $65.41M $70.08M
Total Equity $75.91M $69.08M $93.47M $77.53M $67.56M $63.58M $68.92M $74.10M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$39.74M -$39.43M -$32.54M -$33.64M -$23.05M -$17.55M -$15.56M -$12.54M -$10.38M -$8.30M
Depreciation & Amortization -- $1.4K $2.7K $2.9K $1.5K $844 $893 $1.8K $2.6K $1.3K
Stock-Based Compensation $10.84M $11.84M $6.62M $3.91M $1.45M $803K $716K $780K $987K $732K
Change in Inventory -$12.65M -$2.13M -- -- -- -- -- -- -- --
Change in Payables $8.77M $2.00M $1.76M -$112K -$579K -$857K $1.14M $971K -$307K $105K
Operating Cash Flow -$26.55M -$28.20M -$29.06M -$28.36M -$24.25M -$16.93M -$12.44M -$11.32M -$7.97M -$5.90M
Capital Expenditure -- -- -- -- -$6.9K -$1.8K -- -- -$2.1K --
Free Cash Flow -- -- -- -- -$24.26M -$16.93M -- -- -$7.97M --
Investing Cash Flow -$5.75M -$5.00M -- -- -$40.01M -$1.8K -- -- -$2.1K $256K
Common Stock Issued $32.30M $13.80M -- -- $500 -- -- -- -- --
Financing Cash Flow $33.30M $9.97M $13.83M -- $120.5M $22.90M $11.15M $17.30M $10.88M $5.26M
Net Change in Cash $1.00M -$23.23M -$15.23M -$28.36M $56.21M $5.97M -$1.29M $5.98M $2.91M -$382K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$11.92M -$28.11M -$9.39M -$8.74M -$9.20M -$11.51M -$10.28M -$11.08M
Depreciation & Amortization -- -- -- -- -- -- -- $0
Stock-Based Compensation $3.81M $3.79M $4.28M $2.89M $2.72M $2.70M $2.52M $2.64M
Change in Inventory $34K -$20K -$353K -$3.71M -$1.87M -$958K -$6.11M --
Change in Payables -$1.42M -$1.57M -$2.67M $3.60M $726K $2.00M $2.44M $3.26M
Operating Cash Flow -$8.68M -$1.30M -$13.01M -$11.88M -$5.41M -$4.54M -$4.73M -$5.91M
Investing Cash Flow -$2.00M -$600K -$4.40M -- -- -- -- --
Common Stock Issued $4.45M -$63K $20.88M $15.79M $10.47M $3.47M $2.57M --
Financing Cash Flow $23.09M -$1.23M $20.88M $15.79M $11.47M $3.47M $2.57M --
Net Change in Cash $12.42M -$3.13M $3.47M -$1.84M $6.06M -$1.07M -$2.15M -$14.66M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Gross Margin -- -- -- -- -- -- -- 0.0% 0.0% --
Operating Margin -- -- -- -37017.8% -26146.5% -19678.5% -17331.5% -18385.5% -19972.6% --
Net Profit Margin -- -- -- -37378.5% -25616.0% -19497.9% -17291.3% -16715.5% -20769.9% --
Return on Equity (ROE) -55.4% -57.3% -35.8% -32.7% -17.4% -52.1% -57.3% -40.9% -47.3% -49.5%
Return on Assets (ROA) -28.6% -34.4% -31.4% -29.5% -16.2% -40.1% -42.4% -40.4% -42.5% -37.8%
Current Ratio 0.62x 0.40x 5.95x 9.84x 18.28x 3.41x 1.72x 3.16x 1.39x 0.17x
Quick Ratio 0.13x 0.17x 4.58x 9.21x 17.60x 3.38x 1.71x 2.88x 1.30x 0.06x
Debt to Equity 4.45x 0.00x 0.01x 0.01x 0.01x 0.03x 0.04x -- -- --
Revenue Growth (YoY) -- -- -- 0.0% 0.0% 0.0% +20.0% +50.0% -- --
5Y Revenue / Share Growth -- -- -- -93.2% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -69.5% -75.1% -45.6% -57.1% -64.7% -72.3% -62.6% -30.5%
Return on Assets (ROA) -32.5% -34.9% -26.0% -29.4% -33.0% -36.1% -33.9% -18.3%
Current Ratio 0.84x 0.58x 0.99x 0.62x 0.47x 0.37x 0.41x 0.40x
Quick Ratio 0.40x 0.16x 0.40x 0.13x 0.14x 0.06x 0.09x 0.17x
Debt to Equity 4.52x 4.89x 3.76x 4.45x 4.62x 4.96x 4.59x 0.00x
Net Income Growth (YoY) -- -- -- -- -- -- -211.4% --
Source: SEC EDGAR CompanyFacts (CIK 0001506251) · from September 30, 2010 Data through June 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal